摘要
Sarcopenia is one of the common complications for cirrhotic patients on the waiting list of liver transplantation(LT),which has proven to be the best therapy for end-stage liver disease(ESLD).Some severe complications,including ascites,variceal bleeding,coagulation disorders and hepatic encephalopathy,were carefully managed by clinical physicians.Comparing with these complications,sarcopenia does not affect the mortality during hospitalization that much,even though it might have negative effects on patients’long-term quality of life(QOL)or even survival.
